Is Sangamo Biosciences, Inc. (SGMO) a Good Stock to Invest in?

We already know that not all hedge funds are bullish on the stock and some hedge funds actually dropped their positions entirely. At the top of the heap, Malcolm Fairbairn’s Ascend Capital dropped the biggest position of all the hedgies monitored by Insider Monkey, comprising an estimated $2.4 million in stock. Stuart Weisbrod’s fund, Iguana Healthcare Management, also dumped its stock, worth about $700,000.

Let’s go over hedge fund activity in other stocks – not necessarily in the same industry as Sangamo Biosciences, Inc. (NASDAQ:SGMO) but similarly valued. These stocks are Village Super Market, Inc. (NASDAQ:VLGEA), AG Mortgage Investment Trust Inc (NYSE:MITT), Career Education Corp. (NASDAQ:CECO), and Cascade Bancorp (NASDAQ:CACB). This group of stocks’ market valuations match SGMO’s market valuation.

As you can see these stocks had an average of nine investors holding long positions and the average amount invested in these stocks was $58 million. That figure was $60 million in SGMO’s case. Career Education Corp. (NASDAQ:CECO) is the most popular stock in this table, while Village Super Market, Inc. (NASDAQ:VLGEA) is the least popular one with only five bullish hedge fund positions. Compared to these stocks Sangamo Biosciences, Inc. (NASDAQ:SGMO) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.